Review your findings from Assessment 3 (analysis of congestive heart failure PICOT) & Create an online poster presentation based on your findings. Include: (already noted in the paper created in t
Analysis of Congestive Heart Failure (CHF)
Student Name
Department and Institution Name
Course Title and Course Name
Instructor Name
Due Date
Analysis of Congestive Heart Failure (CHF)
Introduction
Congestive Heart Failure (CHF) is an ineffective heart function, which compromises the body's blood supply that significantly interfere with patients' day-to-day activities and is one of the primary causes of hospital admissions among the elderly. Effective CHF intervention plays a crucial role in controlling severe fluid buildup in patients, decreasing hospital emergency visits while improving patients' health conditions. Loop diuretics and other diuretic therapies have remained crucial in chronic heart failure management throughout the past decades because they effectively reduce fluid retention and congestive issues. The development of newer diuretic treatment options produces promising opportunities to enhance patient outcome. The research investigates the effectiveness of new treatments against traditional CHF therapy regarding their impact on reducing hospital admission numbers and patients' quality of life.
PICOT Question
In older adult patients diagnosed with Congestive Heart Failure (CHF), how do novel diuretic therapies compared to standard treatments affect hospital readmission rates and quality of life within 90 days?
PICO (T) process
Patient/Population/Problem (P): Elderly patients diagnosed with Congestive Heart Failure (CHF).
Intervention (I): Novel diuretic therapies.
Comparison(C): Standard diuretic treatments
Outcome (O): Reduction in hospital readmission rates and improvement in quality of life.
Time (T): Within 90 days post-intervention.
Literature Search Process
The literature search process employed includes first identifying credible databases that are known for publishing credible and peer-reviewed journals. The identified databases include PubMed which is known for hosting resources for biomedical literature, Cumulative Index to Nursing and Allied Health Literature (CINAHL) which focuses on nursing and allied health journals and Google Scholar which hosts a broad spectrum of scholarly articles. The key terms that will be used to facilitate the scholarly article search include congestive heart failure, novel diuretic therapies, and congestive heart failure and novel diuretic therapies. The inclusion criteria for the journal that will be included in this research include only peer-reviewed articles that were published within the last five years, studies that were focused on older adult patients with CHF, and journals that compared various treatment therapies of congestive heart failure with novel diuretic therapy and effectiveness of each therapy and sides effects.
Analysis of the Evidence
The article, “Diuretic Therapy for Patients with Heart Failure” by Felker, et al., (2020) examines how diuretics play an active role in the management of health failure. The authors stress the importance of early treatment of congestion. The study established that diuretic drugs are effective drugs for the management of heart failure as it helps in patient fluid retention. Also, the research demonstrates that although loop diuretics have dominated therapy for more than half a century modern approaches like subcutaneous furosemide are now being developed. The new delivery approaches have dual purposes to simplify patient outreach and possibly enhance treatment results (Felker, et al., 2020). Numerous elements are supporting the credibility of the study. The publication appeared in a peer-reviewed journal because it underwent examination by field experts. Additionally, the study gains credibility because the authors comprise experienced cardiologists and because the journal was published in the Journal of the American College of Cardiology indicating that the journal is reliable and credible. The journal is relevant as it provides essential material associated with both CHF diagnoses and new medication approaches for fluid control that surpass the efficacy of traditional options.
The article, “Diuretic Treatment in Patients with Heart Failure” by Cuthbert, & Clark, (2024) reviews the data from current trials supporting various diuretic techniques, the history of diuretic treatment, and possible future research directions. Cuthbert, & Clark, (2024) found that there is evidence that patients with heart failure benefit more from high-dose loop diuretics than low-dose ones. Compared to doses of low-dose medication, the continuous infusion of a high-dose loop diuretic produces a higher diuresis without the need for treatment escalation. Also, hospitalization for severe fluid retention was the most common cause of morbidity in patients since high-dose loop diuretic treatment alone was sufficient (Cuthbert, & Clark, 2024). The journal is peer-reviewed as it was published in the Pubmed database. It was authored by cardiologist experts working in the cardiologist department in various hospitals Hull York Medical School Castle Hill Hospital and other hospital facilities. The journal is relevant as it published relevant information regarding the effectiveness of loop diuretics based on dosage and other medication.
The article, “A novel strategy to reduce the Readmission Rates in congestive heart failure: Intermittent Empirical Intravenous Diuretics.” by Yetkin et al., (2020) evaluates the effectiveness of intravenous diuretic treatment strategies in reducing hospitalization and managing patients with compensated congestive heart failure (Yetkin et al., 2020). The finding indicates that intermittent empirical intravenous diuretic administration post-discharge in reducing readmission rates for CHF patients was effective in reducing hospitalization. Preliminary reports suggest that so far this approach was a more safe and effective way of decongesting homodynamically stable patients and potentially reducing hospitalization for HF and reduce overall healthcare-related costs (Yetkin et al., 2020). The journal is also credible as it is a peer-reviewed journal published in the PubMed database by experts working in various Hospital departments of cardiology in Istanbul Turkey. Also, the journal provides clinical evidence supporting innovative diuretic approaches in CHF management and it still is relevant because it offers practical insights into novel diuretic strategies and how it has effectively helped reduce hospital readmission and align with the intended outcome as specified in the PICOT Question.
Answering PICO(T) Question
The assessment of available evidence demonstrates how new diuretic treatments have been successful in improving the health of CHF patients especially in reducing readmission and hospital further reducing costs associated with hospitalization for the facility. Research demonstrates that subcutaneous furosemide delivery as well as timed intravenous empirical diuretic approaches during post-hospital care decrease readmissions effectively while improving patient well-being. These alternative strategies help overcome traditional loop diuretic limitations by providing better fluid retention management possibilities to CHF patients.
Conclusion
Effective CHF intervention plays a crucial role in controlling severe fluid buildup in patients and decreases hospital emergency visits while improving patients' health conditions. Loop diuretics and the integration of other diuretic therapies have remained crucial in chronic heart failure management throughout the past decades because they effectively reduce fluid retention and congestive issues. Healthcare professionals should incorporate new diuretic treatments for Congestive Heart Failure management because they demonstrate the potential to both decrease readmissions and improve patient well-being. New approaches need further research to ensure their use in standard medical care through evidence-based validation methods since current intravenous diuretic administration is not included as part of the guidelines for the management of CHF.
References
Cuthbert, J. J., & Clark, A. L. (2024). Diuretic Treatment in Patients with Heart Failure: Current Evidence and Future Directions - Part I: Loop Diuretics. Current heart failure reports, 21(2), 101–114. https://doi.org/10.1007/s11897-024-00643-3
Felker, G. M., Ellison, D. H., Mullens, W., & Cox, Z. L. (2020). Diuretic Therapy for Patients with Heart Failure: JACC State-of-the-Art Review. Journal of the American College of Cardiology, 75(10), 1178-1195. https://www.jacc.org/doi/10.1016/j.jacc.2019.12.059
Yetkin, E., Cuglan, B., Turhan, H., & Ozturk, S. (2020). A novel strategy to reduce the readmission rates in congestive heart failure: intermittent empirical intravenous diuretics. Cardiovascular endocrinology & metabolism, 9(2), 60–63. https://doi.org/10.1097/XCE.0000000000000200
